Find A Doctor Find A Service Make An Appointment Talk To A Doctor

RESEARCHbanner
increase text size decrease text size printer friendly



  • Gynecology

  • Gynecology

    Title(s):
    NRG-GY003. Phase II Randomized Trial of Nivolumab with or without Ipilimumab in Patients with Persistent or Recurrent Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Cancer

    Investigator(s):
    Esther Rehmus, MD

    Contact Information:
    McDowell Cancer Research at 330-344-6348

  • Gynecology

    Title(s):
    NRG-GY004. A Phase III study comparing single-agent olaparib or the combination of cediranib and olaparib to standard platinum-based chemotherapy in women with recurrent platinum-sensitive ovarian, fallopian tube, or primary peritoneal cancer

    Investigator(s):
    Esther Rehmus, MD

    Contact Information:
    McDowell Cancer Research at 330-344-6348

  • Gynecology

    Title(s):
    NRG-GY005. A Randomized Phase II/III study of the combination of Cediranib and Olaparib compared to Cediranib or Olaparib alone, or Standard of care chemotherapy in women with recurrent platinum-resistant or -refractory ovarian, fallopian tube, or primary peritoneal cancer (COCOS)

    Investigator(s):
    Esther Rehmus, MD

    Contact Information:
    McDowell Cancer Research at 330-344-6348

  •  




    Cleveland Clinic Akron General • 1 Akron General Avenue • Akron, OH 44307 • 330.344.6000 • 1.800.221.4601    © 2016 Cleveland Clinic Akron General



    This website is certified by Health On the Net Foundation. Click to verify.

      This site complies with the HONcode standard for trustworthy health information: verify here.